These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38972985)

  • 1. The C-terminal proline-rich repeats of Enteropathogenic E. coli effector EspF are sufficient for the depletion of tight junction membrane proteins and interactions with early and recycling endosomes.
    Ansari I; Mandal A; Kansal K; Walling P; Khan S; Aijaz S
    Gut Pathog; 2024 Jul; 16(1):36. PubMed ID: 38972985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation.
    Singh AP; Sharma S; Pagarware K; Siraji RA; Ansari I; Mandal A; Walling P; Aijaz S
    Sci Rep; 2018 Feb; 8(1):3719. PubMed ID: 29487356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.
    Tapia R; Kralicek SE; Hecht GA
    Cell Microbiol; 2017 Nov; 19(11):. PubMed ID: 28618099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated transient interaction of ZO-1 and afadin is required for pedestal maturation induced by EspF from enteropathogenic Escherichia coli.
    Ugalde-Silva P; Navarro-Garcia F
    Microbiologyopen; 2019 Dec; 8(12):e931. PubMed ID: 31568664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attaching-and-Effacing Pathogens Exploit Junction Regulatory Activities of N-WASP and SNX9 to Disrupt the Intestinal Barrier.
    Garber JJ; Mallick EM; Scanlon KM; Turner JR; Donnenberg MS; Leong JM; Snapper SB
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):273-288. PubMed ID: 29675452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteropathogenic
    Tapia R; Kralicek SE; Hecht GA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo.
    Shifflett DE; Clayburgh DR; Koutsouris A; Turner JR; Hecht GA
    Lab Invest; 2005 Oct; 85(10):1308-24. PubMed ID: 16127426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bacterial virulence factor NleA's involvement in intestinal tight junction disruption during enteropathogenic E. coli infection is independent of its putative PDZ binding domain.
    Thanabalasuriar A; Koutsouris A; Hecht G; Gruenheid S
    Gut Microbes; 2010 Mar; 1(2):114-118. PubMed ID: 21326920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.
    Dean P; Kenny B
    Mol Microbiol; 2004 Nov; 54(3):665-75. PubMed ID: 15491358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis.
    Viswanathan VK; Weflen A; Koutsouris A; Roxas JL; Hecht G
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1165-70. PubMed ID: 18356531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EspF Interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability.
    Peralta-Ramírez J; Hernandez JM; Manning-Cela R; Luna-Muñoz J; Garcia-Tovar C; Nougayréde JP; Oswald E; Navarro-Garcia F
    Infect Immun; 2008 Sep; 76(9):3854-68. PubMed ID: 18559425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals.
    Xia X; Liu Y; Hodgson A; Xu D; Guo W; Yu H; She W; Zhou C; Lan L; Fu K; Vallance BA; Wan F
    PLoS Pathog; 2019 Jun; 15(6):e1007898. PubMed ID: 31251784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
    Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration.
    Glotfelty LG; Zahs A; Hodges K; Shan K; Alto NM; Hecht GA
    Cell Microbiol; 2014 Dec; 16(12):1767-83. PubMed ID: 24948117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterohemorrhagic
    Hua Y; Wu J; Fu M; Liu J; Li X; Zhang B; Zhao W; Wan C
    Front Cell Dev Biol; 2020; 8():613061. PubMed ID: 33425920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteropathogenic Escherichia coli remodels host endosomes to promote endocytic turnover and breakdown of surface polarity.
    Kassa EG; Zlotkin-Rivkin E; Friedman G; Ramachandran RP; Melamed-Book N; Weiss AM; Belenky M; Reichmann D; Breuer W; Pal RR; Rosenshine I; Lapierre LA; Goldenring JR; Aroeti B
    PLoS Pathog; 2019 Jun; 15(6):e1007851. PubMed ID: 31242273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.
    McNamara BP; Koutsouris A; O'Connell CB; Nougayréde JP; Donnenberg MS; Hecht G
    J Clin Invest; 2001 Mar; 107(5):621-9. PubMed ID: 11238563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteropathogenic Escherichia coli infection leads to appearance of aberrant tight junctions strands in the lateral membrane of intestinal epithelial cells.
    Muza-Moons MM; Schneeberger EE; Hecht GA
    Cell Microbiol; 2004 Aug; 6(8):783-93. PubMed ID: 15236645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
    Viswanathan VK; Koutsouris A; Lukic S; Pilkinton M; Simonovic I; Simonovic M; Hecht G
    Infect Immun; 2004 Jun; 72(6):3218-27. PubMed ID: 15155623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.
    Morampudi V; Graef FA; Stahl M; Dalwadi U; Conlin VS; Huang T; Vallance BA; Yu HB; Jacobson K
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.